Literature DB >> 1705421

Establishment of monoclonal antibodies against human acidic fibroblast growth factor.

Y Ichimori1, Y Kinoshita, T Watanabe, M Seno, K Kondo.   

Abstract

Four kinds of hybridomas secreting monoclonal antibodies (MAbs) against human acidic fibroblast growth factor (haFGF) were established using recombinant haFGF as an immunogen. The recognition sites of four MAbs designated AF1-52, 81, 114 and 1C10 for the haFGF molecule were examined by binding studies with synthetic polypeptides and with amino-terminal truncated forms of haFGF. These experiments suggested that AF1-52, 114, and 1C10 MAbs recognize epitopes within the 1-5, 44-132 and 6-43 amino acid sequences, respectively. However, the epitope recognized by the AF1-81 MAb could not be determined. The sandwich EIA method constructed with these MAbs was sensitive to 1.5 pg/well of haFGF and had no cross-reactivity with human basic FGF, bovine aFGF or the hst-1 gene product.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705421     DOI: 10.1016/s0006-291x(05)81233-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  2 in total

1.  Fibroblast growth factors: an epigenetic mechanism of broad spectrum resistance to anticancer drugs.

Authors:  S Song; M G Wientjes; Y Gan; J L Au
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

2.  Expression patterns of acidic and basic fibroblast growth factor in loach fish embryos.

Authors:  K Inaba; M Seno; H Morino
Journal:  Fish Physiol Biochem       Date:  1996-08       Impact factor: 2.794

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.